The Global Crisis of Drug-Resistant Tuberculosis and the Leadership of the BRICS Countries: Challenges and Opportunities
The increasing burden of drug-resistant tuberculosis introduces new challenges to traditional TB control and treatment programs and calls upon the global health community to collaborate and share scientific information in new and different ways. This 3-day workshop is sponsored by the Forum on Drug Discovery, Development, and Translation of the U.S. National Academy of Sciences, Institute of Medicine (IOM) and the Institute of Microbiology of the Chinese Academy of Sciences (CAS). Following an inaugural meeting in Washington, D.C. in 2008, this workshop in Beijing is the fourth in a series of international workshops convened by the U.S. IOM. The objective of the workshop series is to realistically assess the impact of and challenges resulting from drug-resistant TB globally and in the four countries with the most people affected (China, India, Russia, and South Africa). A public workshop was also convened in July/August 2012 in Washington, DC to identify opportunities to improve the global supply chain for second-line TB drugs. Specifically the goals of the workshop series include:
Consider a wide spectrum of issues pertaining to the science and policy around drug-resistant tuberculosis – from biology, epidemiology, and surveillance; to diagnosis, treatment, and infection control; to issues pertaining to the drug supply chain, laboratory capacity, and needs of vulnerable populations. Each workshop will address some or all of these multiple disciplines and facilitate discussion about a global “blueprint for action.”
Present promising new research, and also to identify specific gaps in knowledge and consider potential needs for additional research, funding, and international attention.
The workshop series has been hosted over a period of several years, creating a venue and body of knowledge that explicitly considers and addresses developments over a period of time, thus permitting relatively quick adjustments in knowledge and strategy. The workshop series convenes international experts, permitting exchange of information among experts from each of the participating countries and globally. Each workshop in the series results in a U.S. National Academies publication summarizing the workshop presentations and discussions.
This workshop in Beijing will address the current status of drug-resistant tuberculosis globally, and in China, and consider lessons learned from the other three high burden countries; highlight global challenges to controlling the spread of drug-resistant strains; and discuss innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. The workshop will consider urgent themes relating to the problem of multidrug-resistant (MDR) TB, extensively drug resistant (XDR) TB, and emergent TB strains that are potentially untreatable with drugs available and will consider the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB.